mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.33 |
0.06 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.06 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |